Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial

Autor: Saland, Jeffrey M., Lieske, John C., Groothoff, Jaap W., Frishberg, Yaacov, Shasha-Lavsky, Hadas, Magen, Daniella, Moochhala, Shabbir H., Simkova, Eva, Coenen, Martin, Hayes, Wesley, Hogan, Julien, Sellier-Leclerc, Anne-Laure, Willey, Richard, Gansner, John M., Hulton, Sally-Anne
Zdroj: In Kidney International Reports July 2024 9(7):2037-2046
Databáze: ScienceDirect